Hormone replacement therapy in early menopause pt shows significantly reduced cardiac disease without any apparent increase in risk of cancer, CVA or blood clot

Posted By on October 24, 2012

BMJ (British Medical Journal pubslished in October 9, 2012 edition a study of 1,006 health women age 45-58 recently menopausal or perimenopausal women followed for 10 years.  After 10years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure or myocardial infarction (heart attack) without any apparent increase in risk of cancer, blood clot or stroke.

Share

About The Author

Comments